首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy
【24h】

Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy

机译:抗磷脂酶A2受体抗体与膜性肾病的恶性肿瘤

获取原文
获取原文并翻译 | 示例
           

摘要

In developed countries, the vast majority (70%-80%) of membranous nephropathy cases are idiopathic (iMN), whereas the remainder are due to various secondary causes, such as autoimmune or infectious diseases, drugs, or malignancies. An association between MN and malignancy has been described for decades and accounts for ~ 1.0% of patients with MN. " Previous studies reported that MN could appear as a paraneoplastic syndrome months and sometimes years before a (most often solid) tumor can be detected.
机译:在发达国家,绝大多数(70%-80%)的膜性肾病病例是特发性(iMN),而其余原因是各种继发性原因,例如自身免疫性或传染性疾病,药物或恶性肿瘤。 MN与恶性肿瘤之间的关联已有数十年的历史,约占MN患者的1.0%。先前的研究报道,MN可能在检测到(最常为实体)肿瘤之前数月甚至数年出现为副肿瘤综合症。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号